Publications by authors named "Elif P Coskun"
Alzheimers Dement (N Y)
September 2024
Article Synopsis
- The introduction discusses the concerns surrounding the use of disease-modifying therapies for Alzheimer's disease, such as their clinical benefits, risks, costs, and the hesitation of clinicians to prescribe them.
- The study compares lecanemab, an anti-amyloid therapy for Alzheimer's, with four other biologic agents used in various diseases, focusing on their costs, benefits, and risks.
- Results indicate that the costs, clinical benefits, and safety of anti-amyloid therapies are similar to those of the other biologics, suggesting a promising future for Alzheimer's treatments.
